Is Hers Legit? Hers Weight Loss Reviews, GLP-1 Prices and the Real Monthly Cost
Hers is one of the most-searched GLP-1 brands in the US — roughly 97,000 monthly searches across its weight-loss queries in our DataForSEO demand data (August 2026) — and since March 2026 it sells only FDA-approved medication. We read every price on forhers.com, its 10,000-review Trustpilot profile, the FDA warning letter and the FTC complaint, to answer the question straight.
Medically reviewed by Dr. A. Goher, MD. Sources cited from PubMed & FDA.gov. See our standards
Quick Answer: Is Hers Legit?
Yes — Hers is a legitimate, publicly traded telehealth company (NYSE: HIMS) whose weight-loss program now prescribes only FDA-approved brand GLP-1s: Wegovy pill and pen, Zepbound, Ozempic and Foundayo. But the advertised “from $149/mo” is the medication alone; a separate membership adds $39 the first month and $149/mo after, so the real cost starts at $298/mo. Its forhers.com Trustpilot rating is 3.3/5 from 10,071 reviews (24% one-star), the FDA issued Hers a warning letter on September 9, 2025 over compounded-semaglutide marketing, and the FTC, California and Utah sued the parent company on July 29, 2026 over billing and data-sharing practices — allegations Hims & Hers disputes. Legit, brand-only, and expensive: 4.3x the $69/mo that Embody charges for compounded semaglutide.
The providers we track and verify
We have no commercial relationship with Hers, so we cannot monitor its pricing or fulfilment the way we do the programs below. These are the ones we check every week.
Hers Weight Loss Reviews: What the 3.3-Star Rating Actually Covers
The forhers.com Trustpilot profile holds a 3.3/5 “Average” TrustScore from 10,071 reviews (Trustpilot, verified August 31, 2026). The distribution is the telling part: 38% five-star against 24% one-star, with 14% four, 15% three and 9% two. Nearly a quarter of reviewers had a bad enough experience to leave one star. Hers has claimed the profile since February 2019, pays for a Trustpilot subscription, and replies to 99% of negative reviews, typically within a week. The sibling Hims brand scores lower still — 2.9/5 from 9,170 reviews.
Two scope caveats. First, this is a whole-brand profile, categorised as an Online Pharmacy: it mixes hair, skin, mental-health and birth-control customers with weight-loss customers, so it is evidence about the company, not a clean read on the GLP-1 program. Second, it is why we do not publish a Trustpilot score for Hers on our review pages — for providers whose profile covers several businesses we score on our own five-pillar methodology instead.
What the recent one- and two-star reviews say is still useful, because the same three themes recur in reviews dated the week we checked. Billing and membership surprises lead: reviewers describe being charged the membership fee without receiving product, being billed after cancelling, and monthly totals stepping up from $149 to $199 to $349 as doses increased. Shipping delays come second — orders unshipped for a month, or a scheduled dose step-up that never arrived. Third is the absence of a human: several reviewers say it is impossible to reach a person and that the app is where the relationship lives. Trustpilot's own review summary for the profile notes that customers consistently cite price as a negative.
What Hers Sells for Weight Loss in 2026
Verified on forhers.com on August 31, 2026. Every option is a brand-name, FDA-approved product; there is no compounded semaglutide or tirzepatide on the menu. Every price is a “from” price — Hers states that dosage and titration are at the provider's discretion and that pricing may vary by dosage — and every one carries the note “Membership required”.
Hers GLP-1 menu and all-in cost, verified August 2026
| Option | What it is | Medication from | First month all-in | Ongoing all-in |
|---|---|---|---|---|
| Wegovy Pill | Oral semaglutide (FDA-approved) | $149/mo | $188 | $298/mo |
| Wegovy Pill Microdosing Plan | Oral semaglutide, low-dose schedule | $149/mo | $188 | $298/mo |
| Wegovy Pen | Injectable semaglutide, 0.25 mg–7.2 mg | $199/mo | $238 | $348/mo |
| Foundayo Pill | Oral orforglipron (FDA-approved April 2026) | $149/mo | $188 | $298/mo |
| Ozempic Pill | Oral semaglutide; type-2-diabetes label, eligibility-gated | $149/mo | $188 | $298/mo |
| Ozempic Pen | Injectable semaglutide; type-2-diabetes label, eligibility-gated | $199/mo | $238 | $348/mo |
| Zepbound Vial | Injectable tirzepatide (FDA-approved) | $299/mo | $338 | $448/mo |
| Zepbound KwikPen | Injectable tirzepatide (FDA-approved) | $299/mo | $338 | $448/mo |
All-in = advertised “from” medication price + Hers Weight Loss Membership ($39 first month, then $149/mo, billed separately, does not include or guarantee a prescription). Hers also lists brand Mounjaro and Zepbound at a $1899/mo retail tier. Ozempic and Mounjaro are approved for type 2 diabetes and are available only to patients who meet clinical criteria. Medication pages are marked FSA/HSA-eligible; a smart scale ($55 value) is included if you opt in.
The number that matters is in the fine print, and Hers does print it: the medication price “does not include” the membership, and medication “is not available without a membership”. So the honest headline is not $149/mo. It is $188 for the first month and $298/mo after that for the cheapest option, rising to $348/mo for the Wegovy pen and $448/mo for Zepbound — before any dose-related increase.
Worth knowing: Hers' medication prices of $149 for the Wegovy pill and $199 for the pen are the same self-pay figures Novo Nordisk offers directly, which we track on our Wegovy cost page. The $149/mo membership is therefore the price of the Hers wrapper — the app, the asynchronous provider review, messaging and shipping — not a discount on the drug.
What Happened to Hers' Compounded Semaglutide
Until early 2026 Hims & Hers was one of the biggest telehealth sellers of compounded semaglutide in the United States. On March 9, 2026 the company announced a strategic shift for its US weight-loss business (investor release): it would no longer advertise compounded GLP-1s, would give existing patients the opportunity to move to FDA-approved medicines, and would keep compounded semaglutide only “on a limited scale” for patients whose clinical needs a provider decides cannot be met by an approved product. Novo Nordisk dismissed its lawsuit against the company the same day, without prejudice. By March 26, Novo's FDA-approved GLP-1s — including the Wegovy pill — were live on the platform.
On August 31, 2026 the word “compounded” appeared nowhere on forhers.com's weight-loss pages, FAQ, or its 1,998-URL sitemap. In practice, for a new customer, Hers is a brand-only program. That is a genuine safety positive — an FDA-approved finished product, at a published price — and a genuine cost negative, because compounded semaglutide from the providers we track starts at $69/mo all-in.
The Regulatory Record
Two entries on the public record, both verified against the primary source, and both worth reading in proportion.
FDA warning letter, September 9, 2025. The FDA's Center for Drug Evaluation and Research reviewed forhers.com in August 2025 and warned Hims & Hers Health, Inc. dba Hers (MARCS-CMS 716825) that its claims for compounded semaglutide — describing it as having the same active ingredient as Ozempic and Wegovy, with clinically proven ingredients — were false or misleading, making the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. A matching letter went to the Hims brand the same day. This is a letter about marketing claims, not a finding that anyone was harmed, and the products it concerns have since been removed from the site. Hers is one of a long list of telehealth firms the FDA has warned on the same grounds; several providers we track have received similar letters and we disclose each one on its review page.
FTC lawsuit, July 29, 2026. The Federal Trade Commission, joined by Utah and California, sued Hims & Hers in the Northern District of California (FTC press release). The complaint alleges the company charges for prescriptions almost immediately after an intake form is submitted without clearly disclosing that, makes subscriptions hard to cancel, and shared customers' health information with Meta, Snap and other third parties despite privacy promises. The release does not single out the weight-loss program. These are allegations, and Hims & Hers responded the same day that it will vigorously defend itself and considers the claims baseless. We will update this page when the court rules.
Better Business Bureau. Hims & Hers Inc. has been BBB-accredited since February 2018 but currently carries no rating (“NR”), with 4,427 complaints in the last three years and 1,326 closed in the last twelve months. BBB summarises the complaints on file as concerning cancelled orders and refund requests — the same seam the Trustpilot reviews describe.
How Hers Compares on Price to Providers We Track
This comparison is deliberately not apples-to-apples, and we say so: Hers dispenses FDA-approved brand products, while the cheapest programs we track dispense compounded semaglutide and tirzepatide from licensed US pharmacies. Same molecules, different regulatory status, very different price.
| Program | Semaglutide | Tirzepatide | Product | Tracked? |
|---|---|---|---|---|
| Hers (all-in, incl. membership) | $298–$348/mo | $448/mo | Brand (Wegovy / Zepbound) | No — not verified by us |
| Embody#1 pick | $69/mo | $119/mo | Compounded | Yes |
| SnagRx | $69/mo | $119/mo | Compounded | Yes |
| Bodybuilding.com Health+ | $99/mo | $129/mo | Compounded | Yes |
| Trimi | $99/mo | $125/mo | Compounded | Yes |
| bmiMD | $119/mo | $179/mo | Compounded | Yes |
Tracked prices verified for the August 31, 2026 snapshot of our GLP-1 Price Index (42 providers; cheapest semaglutide $69, cheapest tirzepatide $119). Hers prices read from forhers.com the same day and include the $149/mo membership.
In multiples: the cheapest Hers option is about 4.3x the cheapest tracked compounded semaglutide, and Zepbound at Hers about 3.8x the cheapest tracked compounded tirzepatide. Over a year the semaglutide gap is roughly $2748. What the premium buys is real: an FDA-approved finished product with the manufacturer's quality controls, which compounded drugs do not have. What it does not buy is a different molecule — semaglutide is the drug studied in STEP-1 (New England Journal of Medicine, 2021, roughly 15% average weight loss) and tirzepatide the drug in SURMOUNT-1 (NEJM, 2022, roughly 21%), whoever dispenses them.
What the Hers $149/mo Weight Loss Membership Includes
The Hers Weight Loss Membership costs $39 for the first month and $149/mo after, is billed separately from the medication, and does not include or guarantee a prescription. For that fee Hers provides a state-licensed provider's review of your intake, in-app messaging, shipping, partner offers and an opt-in smart scale. It does not bill insurance, is not available in all 50 states, and does not publish a clinician roster or the name of the dispensing pharmacy.
- Cancel anytime, but cancel both. Cancelling the membership ends the medication plan and access to care; cancelling only the medication plan leaves the $149/mo membership running. Sales are final per the terms quoted on its BBB profile.
- A state-licensed provider reviews your intake and, depending on your state, may prescribe without a video visit; if a visit is required, it is scheduled as a video or audio call. Hers does not publish a clinician roster or the name of the pharmacy that fills weight-loss prescriptions, which is a transparency deduction under our methodology.
- No insurance, by design. Hers says insurance is not required and does not bill it; medication pages are FSA/HSA-eligible and Hers recommends paying by card and claiming reimbursement yourself.
- Not all 50 states. Hers states that GLP-1s are not yet available in every state and that it is working to expand; it does not publish a state list or count.
- Membership perks — Hers lists partner offers from HelloFresh, Factor, Ladder, MyFitnessPal, Eight Sleep and Natural Cycles, plus an opt-in smart scale.
Who Hers Suits — and Who It Doesn't
Hers is a reasonable pick if…
- You specifically want an FDA-approved brand product — Wegovy, Zepbound or the new Foundayo pill — and no compounded drug.
- You want the whole thing inside one app and are willing to pay $149/mo for that convenience.
- You prefer an oral option; the Wegovy pill, Foundayo pill and Ozempic pill are all on the menu.
- You can budget $298–$448/mo cash with no insurance offset.
Look elsewhere if…
- You want semaglutide at the lowest defensible price — the gap to compounded is 4.3x.
- You have insurance that covers Wegovy or Zepbound; your own pharmacy will beat Hers' cash price.
- You want to talk to a human when billing goes wrong — that is the most repeated complaint.
- The Novo self-pay price is available to you directly; Hers charges the same for the drug, plus membership.
Is Hers Legit? Frequently Asked Questions
Is Hers legit?
Yes. Hers is the women's brand of Hims & Hers Health, Inc., a publicly traded company (NYSE: HIMS) founded in 2017 and headquartered in San Francisco. Its weight-loss program uses state-licensed providers, its parent company files audited financial statements with the SEC, and every GLP-1 it currently lists — Wegovy, Zepbound, Ozempic and Foundayo — is an FDA-approved brand product. "Legit" is not the same as "clean", though: the forhers.com Trustpilot profile sits at 3.3/5 from 10,071 reviews with 24% one-star, the FDA sent Hers a warning letter on September 9, 2025 over how it marketed compounded semaglutide, and the FTC, California and Utah sued the parent company on July 29, 2026 over billing, cancellation and health-data practices. Hims & Hers disputes the FTC allegations.
How much does Hers weight loss cost per month?
From $298 per month all-in. Hers advertises medication "from" prices — Wegovy Pill and Foundayo Pill from $149/mo, Wegovy Pen from $199/mo, Zepbound vial or KwikPen from $299/mo — but each one requires a separate Hers Weight Loss Membership at $39 for the first month and $149/mo after that, and Hers states plainly that the medication price does not include the membership. Realistic totals in August 2026: about $188 for your first month on the Wegovy pill, then $298/mo; $348/mo for the Wegovy pen; $448/mo for Zepbound. Hers also says pricing may vary by dosage, and recent reviewers report bills rising as doses climb.
Does Hers still sell compounded semaglutide?
Not to new customers in any listed form. On March 9, 2026 Hims & Hers announced it would no longer advertise compounded GLP-1s and would move patients to FDA-approved medicines, keeping compounded semaglutide only "on a limited scale" where a provider decides it is clinically necessary; Novo Nordisk dismissed its lawsuit the same day, without prejudice. As of August 31, 2026 the word "compounded" does not appear on forhers.com's weight-loss pages or anywhere in its sitemap. If you want compounded semaglutide at a compounded price, Hers is no longer where you get it.
Does Hers accept insurance for weight loss?
No. Hers states that insurance is not required and does not bill insurers for its weight-loss program; you pay cash for both the membership and the medication. The medication pages are marked FSA/HSA-eligible, and Hers' guidance is to pay by card and submit for reimbursement yourself. If you have coverage for Wegovy or Zepbound, going through your own pharmacy with a prior authorization will usually cost far less than Hers' cash price.
Has Hers received an FDA warning letter?
Yes. On September 9, 2025 the FDA's Center for Drug Evaluation and Research issued a warning letter to Hims & Hers Health, Inc. dba Hers (MARCS-CMS 716825) after reviewing forhers.com in August 2025. The agency said the site's claims for compounded semaglutide — including that it had the same active ingredient as Ozempic and Wegovy and used clinically proven ingredients — were false or misleading, making the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. A matching letter went to the Hims brand the same day. The letters concern marketing claims, not a finding of patient harm, and Hers has since removed compounded products from its site.
Is Hers being sued by the FTC?
Yes, as of July 29, 2026. The Federal Trade Commission, joined by the states of Utah and California, sued Hims & Hers Health in the U.S. District Court for the Northern District of California. The complaint alleges the company charges consumers for prescriptions almost immediately after they submit an intake form without clearly disclosing that, makes subscriptions hard to cancel, and shared customers' health information with Meta, Snap and other third parties despite privacy promises. These are allegations, not findings: Hims & Hers responded the same day that it will vigorously defend itself and called the claims baseless. The FTC's release does not single out the weight-loss program.
Can you cancel Hers weight loss anytime?
Yes, but with two catches. Hers says you can cancel anytime, and that cancelling the membership also cancels any active medication plan and your access to care, while cancelling only the medication plan leaves the membership running at $149/mo. Second, its BBB profile quotes the company's terms as stating that all sales are final and not eligible for a refund. The most common complaint in recent one- and two-star Trustpilot reviews is exactly this seam — membership fees charged without product, or charges continuing after a cancellation — so cancel both the medication plan and the membership, in writing, and keep the confirmation.
Is Hers cheaper than other GLP-1 providers?
No for compounded, roughly even for brand. Hers' medication prices — $149 for the Wegovy pill, $199 for the pen — match the manufacturer's own self-pay prices we track on our Wegovy cost page, so the $149/mo membership is the premium you pay for the Hers app and clinician. Against compounded semaglutide the gap is wide: $298/mo all-in at Hers versus $69/mo at Embody, about 4.3x, for a different (FDA-approved versus compounded) formulation of the same molecule. Hers makes sense if you specifically want an FDA-approved brand product through an app; it is an expensive way to get semaglutide if you do not.
Want the Same Molecule Without the Membership?
Embody dispenses compounded semaglutide from $69/month, billed monthly, with no separate membership fee stacked on top.
Disclaimer: Educational content, not medical advice. GLP-1 medications are prescription drugs; eligibility and dosing are decided by a licensed prescriber. Compounded medications are not FDA-approved finished products. The FTC complaint described above contains allegations that have not been proven in court. GLP-1 Watchdog has no commercial relationship with Hers and does not earn a commission from it; we do earn commission from the tracked providers listed above, which never affects our scoring — see our methodology and affiliate disclosure. Prices verified August 31, 2026 and change often.